Shantha Biotechnics has commissioned a new vaccine production facility in Telangana

July 7, 2016

Drugs & Pharma

Status: Commissioned

Promoter: Shantha Biotechnics

Project: Commissioned a new vaccine production facility

Location: Village Muppireddypally, dist. Medak, Telangana.

Project Details: Construction of the 19,000 sq. mtrs facility began in 2010 and the site is now ready for operations post approval from the Indian regulatory authorities and the World Health Organization. The new filling facility will be used for producing vaccines against multiple diseases, starting with Shan5, pediatric pentavalent vaccine, which provides protection against five diseases in one shot. This site is a part of over Rs. 55,000 million investments undertaken by Sanofi since acquisition of Shantha Biotechnics. Commercial production commenced on 25th May, 2016. An insulin plant being set up with Rs. 4,500 million by the company in the same location is expected to be ready in about a year. According to media reports, the cost of the project is Rs. 2,500 million. This year’s target is to produce 10 million doses of vaccine in the new plant but it could be scaled up to produce up to 30 million doses going forward. It will be used to cater to the requirements of Sanofi as well domestic market.

Advertisements

Somu Chemicals And Pharmaceuticals has commissioned a herbal extract and API manufacturing unit in Karnataka

April 5, 2016

Drugs and Pharma

Status: Commissioned

Promoter: Somu Chemicals And Pharmaceuticals, a part of Somu Group

Project: Commissioned a 65,000 kgs/ yr herbal extract and active pharmaceutical ingredient manufacturing unit

Location: Anekal Taluka, dist. Bengaluru, Karnataka

Project Details: The project is spread over on 10,000 sq. ft. The estimated cost of the project is Rs. 34.2 million. Commercial production commenced in February 2016. According to MoEF sources, the products include 14,000 kgs/ yr herbal extracts, 51,000 kgs/ yr cosmetics ingredients, nutraceutical ingredients, pharma intermediates and API with R&D activity. Effluent generated will be treated in common effluent treatment plant. The total power requirement of the industry is 65 kVA. Greenbelt will be developed in 30% of the total area.


Lewens labs is planning a bulk drug manufacturing unit in dist. Bharuch, Gujarat.

November 12, 2015

Drugs and Pharma

Status: Planning Stage

Promoter: Lewens labs

Project: Plans a 32.36 TPM bulk drug manufacturing unit

Project Location: Dahej, dist. Bharuch, Gujarat

Project Details: The project will spread over 10,000 sq. mtrs. Civil contractor has been appointed. Equipment supplier is yet to be appointed. The cost of the project is Rs. 100 million. Work on the project will commence in December 2015. According to MoEF sources, the company has proposed 3,000 sq. mtrs area for green belt development. Industrial waste water will be treated in Primary, Secondary & Tertiary treatment plant.


Glaxosmithkline Pharmaceuticals is planning a tablet & capsule manufacturing pharmaceutical factory in dist. Kolar, Karnataka.

November 7, 2015

Drugs and Pharma

Status: Planning Stage

Promoter: Glaxosmithkline Pharmaceuticals

Projects: Plans a tablet & capsule manufacturing pharmaceutical factory

Location: Vemagal Industrial Area, dist. Kolar, Karnataka

Project Cost: The cost of the project is Rs. 10 billion.

Project Details: The 50 acres of land was sanctioned by the State government. The factory will make more than 8 billion tablets and 1 billion capsules in the areas of gastroenterology and anti-inflammatory medicines for the Indian market. The factory will be built in partnership with international and local design and construction companies. The facility will also include a warehouse, site infrastructure, employee welfare centre and utilities to support the manufacturing and packing of the medicines. The foundation stone was laid on 8th September 2015. The factory is expected to be fully operational by 2017.


Virupaksha Organics is planning an expansion of its bulk drug & intermediate manufacturing project in Telangana

January 31, 2015

Drugs and Pharma

Status: Planning Stage

Promoter: Virupaksha Organics

Project: Plans an expansion of its bulk drug & intermediate manufacturing unit

Location: IDA, Pashamylaram, dist. Medak, Telangana

Current Status: The project is in paper stage. Other details are yet to be finalized. Work on the project is expected to commence in April 2015.


Eugia Pharma Specialities is implementing an oncology products manufacturing project in Telangana.

December 10, 2014

Drugs and Pharma

Status: Under Implementation

Promoter:  Eugia Pharma Specialities, a subsidiary of Aurobindo Pharma

Project:  Implementing an oncology products (injectables) manufacturing project

Location:  Village Koltur, dist. Rangareddy, Telangana.

Current Status:  Civil work is in progress. The project is scheduled for completion in December 2015. Both indigenous & imported machinery will be used for the project.


Vasudha Pharma Chem is planning a chemical manufacturing project in dist. Visakhapatnam, Andhra Pradesh.

August 26, 2014

Chemicals

Status: Planning Stage
Promoter: Vasudha Pharma Chem
Project: Chemical manufacturing unit
Location: Village Atchutapuram, dist. Visakhapatnam, Andhra Pradesh
Project Detail: The project will spread over 26 acres. Land has been acquired.
Current Status: Work on the project is expected to commence in August 2014 & is planned for completion in 2016.

For More information visit : https://www.indianewprojects.com/business-leads/e-shop